Charles Schwab Investment Management Inc Sangamo Therapeutics, Inc Transaction History
Charles Schwab Investment Management Inc
- $557 Billion
- Q2 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,281,799 shares of SGMO stock, worth $666,535. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,281,799
Previous 1,097,834
16.76%
Holding current value
$666,535
Previous $724,000
4.42%
% of portfolio
0.0%
Previous 0.0%
Shares
32 transactions
Others Institutions Holding SGMO
# of Institutions
125Shares Held
50.6MCall Options Held
1.1MPut Options Held
789K-
Vanguard Group Inc Valley Forge, PA9.37MShares$4.87 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT8.08MShares$4.2 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.84MShares$3.56 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.7MShares$2.45 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.33MShares$1.21 Million0.0% of portfolio
About SANGAMO THERAPEUTICS, INC
- Ticker SGMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 156,552,992
- Market Cap $81.4M
- Description
- Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...